Born in the lab.
Built around DNA.

Moligo grew out of research at Karolinska Institutet. Since 2019, we have brought that work into a company making long single-stranded DNA for research and development.

Our story

From the research bench
to our partners’ laboratories.

2013
Research at Karolinska Institutet leads to an enzymatic method for producing single-stranded DNA, published in Nature Methods.
2019
Cosimo Ducani, Simone Codeluppi and Björn Högberg establish Moligo Technologies to bring enzymatic DNA synthesis into commercial development.
2020
A seed round led by Colibri Ventures supports bringing long ssDNA synthesis to market.
2021
Moligo ships ssDNA to pharmaceutical and academic customers from its own laboratories.
2023
Moligo begins a collaboration with Nationwide Children’s Hospital on long ssDNA for CFTR insertion in airway cells.
2024
Moligo’s European patent is granted.
2025
Research with Cellectis on circular ssDNA for gene insertion in human blood stem and progenitor cells is published in Nature Communications.
Today
Moligo supplies native linear and circular ssDNA and develops modified DNA with selected partners.